| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO | Chief Financial Officer
2 companies
Tulipano Stephen J is a CFO at Stoke Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 12 sells.
Estimated insider holdings value: $672K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2024 | STOK Stoke Therapeutics, Inc. | CFO | Sale+OE | 4,116 | $6.10 | $25,101.84 | -16.6% | +169.0% | +42.4% | |
| Feb 23, 2021 | STOK Stoke Therapeutics, Inc. | CFO | Sale+OE | 30,000 | $58.86 | $1,765,895.79 | -70.9% | - | - | |
| Nov 4, 2020 | STOK Stoke Therapeutics, Inc. | CFO | Sale+OE | 70,000 | $39.00 | $2,729,938.53 | -63.1% | - | - | |
| Feb 17, 2017 | ALDX Aldeyra Therapeutics, Inc. | Chief Financial Officer | Buy | 3,333 | $4.50 | $14,998.50 | New | - | - |